By a News Reporter-Staff News Editor at Gene Therapy Weekly Research and Markets has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Central Nervous System Diseases- Technologies, Markets and Companies" to their offering. The delivery of drugs to central nervous system is a challenge in the treatment of neurological di
By a News Reporter-Staff News Editor at Gene Therapy Weekly Research and Markets has announced the addition of Jain PharmaBiotech's new report "Cardiovascular Drug Delivery- Technologies, Markets and Companies" to their offering. Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and phys
According to news originating from Columbia, Missouri, by NewsRx correspondents, research stated, "An intravascular ultrasound and microbubble drug delivery system was evaluated in both ex vivo and in vivo swine vessel models. Our news journalists obtained a quote from the research from the University of Missouri, "Ultrasound pulse sequences consis
Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing. Acino's products tick the top five purchase factors of highest efficacy, Swiss quality standards, well-proven active ingredients,.
By a News Reporter-Staff News Editor at Biotech Week Research and Markets has announced the addition of Jain PharmaBiotech's new report "Transdermal Drug Delivery- Technologies, Markets, and Companies" to their offering. This report deals with transdermal drug delivery- an approach used to deliver drugs through the skin for therapeutic use as an
Persistence Market Research is released new forthcoming report on title "Injectable Drug Delivery Market: Global Industry Analysis and Forecast to 2020". New York, NY 11/19/2014 Drug delivery is a process of administering pharmaceutical compound through various routes in the body for therapeutic effect. Oral, injection based, transdermal and
Insys Therapeutics, Inc., a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that Michael L. Babich, President and Chief Executive Officer, and Darryl Baker, Chief Financial Officer, will present at the 26th Annual Piper Jaffray Healthcare Conference as follows
New Drug Delivery Systems Findings Reported from Technical University. According to news reporting out of Braunschweig, Germany, by NewsRx editors, research stated, "In the development of colloidal lipid drug delivery systems, the localization of the drug within the DDS, the protective potential of the DDS as well as the compatibility of the drug w
Researchers from Department of Chemistry Report Details of New Studies and Findings in the Area of Drug Delivery Systems. By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on Drugs and Therapies. For more information on this research see: The biocompatibility and water uptake behavior of superparamagnetic poly-
By a News Reporter-Staff News Editor at Biotech Week A new study on Drugs and Therapies is now available. According to news reporting originating from Singapore, Singapore, by NewsRx correspondents, research stated, "An innovative process of integrating microneedle array with carbon nanotube nanofilters is developed for a novel transdermal drug d
According to news reporting originating in Chicago, Illinois, by NewsRx journalists, research stated, "Biological hydrogels are fundamentally biocompatible and have intrinsic similarities to extracellular matrices in medical applications and drug delivery systems. The news reporters obtained a quote from the research from Northwestern University, "
Study Results from University of Health Sciences Update Understanding of Drug Delivery Systems. By a News Reporter-Staff News Editor at Biotech Week A new study on Drugs and Therapies is now available. According to news reporting out of Pomona, California, by NewsRx editors, research stated, "Objective of the present study was to develop a prolip
ALEXANDRIA, Va., Nov. 18 Advanced Cardiovascular Systems, Santa Clara, California, has been assigned a patent developed by Stephen Dirk Pacetti, San Jose, California, for "coatings for drug delivery devices." The patent application was filed on Jan. 4, 2013. Written by Balkishan Dalai; edited by Jaya Anand.
WORCESTER, Mass. and TORONTO, Nov. 18, 2014/ PRNewswire/ Generex Biotechnology Corporation today announced that it has entered into a non-binding Letter of Intent to license the Company's proprietary RapidMist? drug delivery technologies to CannScience Innovations Inc. for the delivery of medicinal cannabis derived products into the bloodstream
This research lead to the expansion of mPhase's Intellectual Property which utilizes mPhase's smart surface technology. x0D;. In February of 2013 mPhase filed a United States Letter Patent Application for a novel drug delivery system based on its Smart Surface technology. In December of 2013 the patent application for the Smart Drug Delivery Syst
In December of 2013 the patent application for the Smart Drug Delivery System received a first review by the United States Patent and Trademark Office. The patent office examiner indicated that a significant portion of the claims were patentable. Under past Cooperative Research and Development Agreements with the United States Army, mPhase develope
NEW YORK, LONDON, BERLIN, and PARIS, November 18, 2014/ PRNewswire/. Reportstack has announced the publication of market research report on Global Pulmonary Drug Delivery Systems Market which is expected to grow at a CAGR of 8.90 percent from 2015-2019. An increase in the prevalence of respiratory diseases like asthma and chronic obstructive pulm
TechNavio has announced the publication of its market research report on the Global Pulmonary Drug Delivery Systems Market, which is expected to grow at a CAGR of 8.90 percent from 2015-2019.. An increase in the prevalence of respiratory diseases like asthma and chronic obstructive pulmonary disease is expected to expand the patient population for.
Bio-Path Holdings, Inc.,, a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the third quarter ended September 30, 2014. Bio-Path is now completing an analysis of the Phase I data and is on schedule to submit the analysis to the U.S. Food and Drug..
By a News Reporter-Staff News Editor at Cancer Gene Therapy Week Research and Markets has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Cancer- Technologies, Markets and Companies" to their offering. Innovative cancer therapies are based on current concepts of molecular biology of cancer. These include antiangiogenic
mPhase Technologies, Inc., announced an update on the Drug Delivery System patent application which was originally filed in February of 2013. The Drug Delivery System is based on mPhase Technologies award winning advanced battery technology. Frost and Sullivan recognized mPhase with its 2013 North American Advanced Battery Technology Innovati